Louise St-Onge

Director, Marketing, Patient Programs and Advocacy

After over five years of leading Market Access and Government Affairs Louise St-Onge embarked on a new role as Director, Marketing, Patient Programs and Advocacy in early 2024.

Having worked in the Canadian rare disease space since 2018, Louise has played an integral role in building Shionogi Canada’s unwavering patient-first philosophy by helping to facilitate timely access to treatment for Canadians living with ALS through patient support programs and advocacy initiatives. Louise now works closely with stakeholders on initiatives to empower and improve the lives of people living with rare diseases and their caregivers through education, advocacy, and community building.

Previously, Louise was leading the market access CNS and oncology portfolios at Teva Innovation. In addition, she has cumulated extensive commercial experience in the pharmaceutical industry, having served in a wide range of roles ranging from field sales to executive leadership.